Corbus Pharmaceuticals Holdings, Inc. Amortization of Debt Discount (Premium)
Corbus Pharmaceuticals Holdings, Inc. (CRBP) reported Amortization of Debt Discount (Premium) of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-09.
Financial Statements › Cash Flow › Operating Activities
us-gaap:AmortizationOfDebtDiscountPremium · last filed 2026-03-09
- Corbus Pharmaceuticals Holdings, Inc. amortization of debt discount (premium) for the quarter ending 2025-12-31 was $0.00.
- Corbus Pharmaceuticals Holdings, Inc. amortization of debt discount (premium) for the quarter ending 2025-09-30 was $0.00, a 100.00% decline year-over-year.
- Corbus Pharmaceuticals Holdings, Inc. amortization of debt discount (premium) for the quarter ending 2025-06-30 was $0.00, a 100.00% decline year-over-year.
- Corbus Pharmaceuticals Holdings, Inc. amortization of debt discount (premium) for the quarter ending 2025-03-31 was $0.00, a 100.00% decline year-over-year.
- Corbus Pharmaceuticals Holdings, Inc. amortization of debt discount (premium) for fiscal 2025 was $0.00, a 100.00% decline from fiscal 2024.
- Corbus Pharmaceuticals Holdings, Inc. amortization of debt discount (premium) for fiscal 2024 was $396.00K, a 51.94% decline from fiscal 2023.
- Corbus Pharmaceuticals Holdings, Inc. amortization of debt discount (premium) for fiscal 2023 was $824.00K, a 10.98% increase from fiscal 2022.
- Corbus Pharmaceuticals Holdings, Inc. amortization of debt discount (premium) for fiscal 2022 was $742.48K, a 5.98% increase from fiscal 2021.
| Period end | Amortization of Debt Discount (Premium) 3 month | Amortization of Debt Discount (Premium) 3 month as first filed | Amortization of Debt Discount (Premium) 6 month | Amortization of Debt Discount (Premium) 6 month as first filed | Amortization of Debt Discount (Premium) 9 month | Amortization of Debt Discount (Premium) 9 month as first filed | Amortization of Debt Discount (Premium) 12 month | Amortization of Debt Discount (Premium) 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | $0.00 derived: sum of 2 quarters · filed 2026-03-09 | $0.00 derived: sum of 3 quarters · filed 2026-03-09 | $0.00 10-K · filed 2026-03-09 | ||||
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $0.00 derived: sum of 2 quarters · filed 2025-11-12 | $0.00 10-Q · filed 2025-11-12 | $0.00 derived: sum of 4 quarters · filed 2026-03-09 | ||||
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | $0.00 10-Q · filed 2025-08-05 | $0.00 derived: sum of 3 quarters · filed 2026-03-09 | $76.00K derived: sum of 4 quarters · filed 2026-03-09 | ||||
| 2025-03-31 | $0.00 10-Q · filed 2025-05-06 | $0.00 derived: sum of 2 quarters · filed 2026-03-09 | $76.00K derived: sum of 3 quarters · filed 2026-03-09 | $208.00K derived: sum of 4 quarters · filed 2026-03-09 | ||||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | $76.00K derived: sum of 2 quarters · filed 2026-03-09 | $208.00K derived: sum of 3 quarters · filed 2026-03-09 | $396.00K 10-K · filed 2026-03-09 | ||||
| 2024-09-30 | $76.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $208.00K derived: sum of 2 quarters · filed 2025-11-12 | $396.00K 10-Q · filed 2025-11-12 | $586.00K derived: sum of 4 quarters · filed 2025-11-12 | ||||
| 2024-06-30 | $132.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | $320.00K 10-Q · filed 2025-08-05 | $510.00K derived: sum of 3 quarters · filed 2025-08-05 | $714.00K derived: sum of 4 quarters · filed 2025-08-05 | ||||
| 2024-03-31 | $188.00K 10-Q · filed 2025-05-06 | $187.67K 10-Q · filed 2024-05-07 | $378.00K derived: sum of 2 quarters · filed 2025-05-06 | $582.00K derived: sum of 3 quarters · filed 2025-05-06 | $810.88K derived: sum of 4 quarters · filed 2025-05-06 | |||
| 2023-12-31 | $190.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-11 | $394.00K derived: sum of 2 quarters · filed 2025-03-11 | $622.88K derived: sum of 3 quarters · filed 2025-03-11 | $824.00K 10-K · filed 2025-03-11 | $824.38K 10-K · filed 2024-03-12 | |||
| 2023-09-30 | $204.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $432.88K derived: sum of 2 quarters · filed 2024-11-07 | $634.00K 10-Q · filed 2024-11-07 | $634.01K 10-Q · filed 2023-11-07 | $836.61K derived: sum of 4 quarters · filed 2024-11-07 | |||
| 2023-06-30 | $228.88K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | $430.00K 10-Q · filed 2024-08-06 | $430.37K 10-Q · filed 2023-08-08 | $632.61K derived: sum of 3 quarters · filed 2024-08-06 | $815.01K derived: sum of 4 quarters · filed 2024-08-06 | |||
| 2023-03-31 | $201.12K 10-Q · filed 2024-05-07 | $403.73K derived: sum of 2 quarters · filed 2024-05-07 | $586.14K derived: sum of 3 quarters · filed 2024-05-07 | $766.70K derived: sum of 4 quarters · filed 2024-05-07 | ||||
| 2022-12-31 | $202.61K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-12 | $385.01K derived: sum of 2 quarters · filed 2024-03-12 | $565.58K derived: sum of 3 quarters · filed 2024-03-12 | $742.48K 10-K · filed 2024-03-12 | ||||
| 2022-09-30 | $182.40K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $362.97K derived: sum of 2 quarters · filed 2023-11-07 | $539.87K 10-Q · filed 2023-11-07 | $768.53K derived: sum of 4 quarters · filed 2023-11-07 | ||||
| 2022-06-30 | $180.56K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $357.46K 10-Q · filed 2023-08-08 | $586.12K derived: sum of 3 quarters · filed 2023-08-08 | $713.98K derived: sum of 4 quarters · filed 2023-08-08 | ||||
| 2022-03-31 | $176.90K 10-Q · filed 2023-05-09 | $405.56K derived: sum of 2 quarters · filed 2023-05-09 | $533.42K derived: sum of 3 quarters · filed 2023-05-09 | $707.23K derived: sum of 4 quarters · filed 2023-05-09 | ||||
| 2021-12-31 | $228.66K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-07 | $356.52K derived: sum of 2 quarters · filed 2023-03-07 | $530.33K derived: sum of 3 quarters · filed 2023-03-07 | $700.61K 10-K · filed 2023-03-07 | ||||
| 2021-09-30 | $127.86K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $301.67K derived: sum of 2 quarters · filed 2022-11-08 | $471.95K 10-Q · filed 2022-11-08 | $521.50K 10-Q · filed 2021-11-12 | $644.37K derived: sum of 4 quarters · filed 2022-11-08 | |||
| 2021-06-30 | $173.81K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $344.09K 10-Q · filed 2022-08-09 | $516.51K derived: sum of 3 quarters · filed 2022-08-09 | |||||
| 2021-03-31 | $170.28K 10-Q · filed 2022-05-10 | $342.70K derived: sum of 2 quarters · filed 2022-05-10 | ||||||
| 2020-12-31 | $172.41K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-08 | $291.39K 10-K · filed 2022-03-08 | ||||||
| 2020-09-30 | $118.98K 10-Q · filed 2021-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |